FDA Approves First Over-the-Counter Continuous Glucose Monitor for Children

The FDA's approval of the first over-the-counter continuous glucose monitor (CGM) for children marks a significant advancement in diabetes management, making it easier for families to monitor young patients without a prescription. This development could lead to more proactive and timely diabetes care, especially for children who might struggle with traditional monitoring methods. With this new CGM, parents and caregivers can keep a closer eye on glucose levels, potentially reducing the risk of complications associated with poorly managed diabetes. The move underscores the importance of accessible and innovative medical technology for improving health outcomes in children.